Holen Sie sich die Stockscreener-App
88.84
1.44%
1.26
Handel nachbörslich:
88.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MET?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$87.58
Offen:
$88.25
24-Stunden-Volumen:
3.15M
Relative Volume:
0.90
Marktkapitalisierung:
$57.16B
Einnahmen:
$77.59B
Nettoeinkommen (Verlust:
$3.62B
KGV:
17.18
EPS:
5.1701
Netto-Cashflow:
$16.53B
1W Leistung:
+5.15%
1M Leistung:
+12.97%
6M Leistung:
+8.13%
1J Leistung:
+12.47%
1-Tages-Spanne:
$88.03
$89.44
1-Wochen-Bereich:
$84.02
$89.44
52-Wochen-Spanne:
$67.33
$89.44
Metlife Inc Stock (MET) Company Profile
Firmenname
Metlife Inc
Sektor
Branche
Telefon
212-578-5500
Adresse
200 PARK AVENUE, NEW YORK, NY
Compare MET vs MFC, AFL, PRU, PUK
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MET
Metlife Inc
|
88.84 | 57.16B | 77.59B | 3.62B | 16.53B | 5.1701 |
MFC
Manulife Financial Corp
|
40.31 | 67.14B | 44.31B | 4.69B | 20.94B | 2.5185 |
AFL
Aflac Inc
|
117.80 | 59.96B | 18.11B | 4.64B | 2.93B | 8.812 |
PRU
Prudential Financial Inc
|
108.50 | 37.68B | 62.83B | 3.60B | 9.79B | 9.7297 |
PUK
Prudential Plc Adr
|
26.58 | 33.23B | 27.81B | 4.12B | 1.87B | 3.07 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-16 | Eingeleitet | Mizuho | Outperform |
| 2025-09-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-09-16 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-23 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2024-10-09 | Eingeleitet | TD Cowen | Buy |
| 2024-09-05 | Eingeleitet | Barclays | Overweight |
| 2024-01-08 | Hochstufung | Goldman | Neutral → Buy |
| 2023-11-17 | Fortgesetzt | Barclays | Overweight |
| 2023-10-05 | Eingeleitet | Deutsche Bank | Hold |
| 2023-09-14 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-09 | Herabstufung | Goldman | Buy → Neutral |
| 2022-12-09 | Herabstufung | Jefferies | Buy → Hold |
| 2022-09-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-06-23 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-05-24 | Eingeleitet | Citigroup | Buy |
| 2022-01-26 | Eingeleitet | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-01-12 | Bestätigt | UBS | Buy |
| 2022-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-04-21 | Eingeleitet | UBS | Buy |
| 2021-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-17 | Eingeleitet | Barclays | Overweight |
| 2020-06-01 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-03-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-07-16 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-03-19 | Herabstufung | Sandler O'Neill | Buy → Hold |
| 2019-01-16 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-01-02 | Hochstufung | Sandler O'Neill | Hold → Buy |
| 2018-06-04 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-25 | Eingeleitet | Credit Suisse | Outperform |
| 2018-03-26 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-01-02 | Eingeleitet | Deutsche Bank | Hold |
| 2017-11-10 | Herabstufung | Sandler O'Neill | Buy → Hold |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-05-25 | Hochstufung | FBR & Co. | Mkt Perform → Outperform |
| 2017-03-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-01-26 | Eingeleitet | Citigroup | Sell |
| 2016-12-09 | Herabstufung | Standpoint Research | Buy → Hold |
Alle ansehen
Metlife Inc Aktie (MET) Neueste Nachrichten
MetLife Appoints Najla Frayha as Chief Marketing Officer, U.S. Group Benefits - hrtoday.in
Is MetLife stock outperforming the S&P 500? - MSN
MetLife Inc. stock outperforms competitors on strong trading day - MarketWatch
MetLife Stadium? Lumen Field? Not during the World Cup - Fast Company
Metlife Preferreds Update: Series A Drops From Hold To Sell; Others Stay Holds (MET.PR.A) - Seeking Alpha
MetLife broadens settlement solutions portfolio with NQA-FA - MSN
MetLife Inc. stock rises Thursday, still underperforms market - MarketWatch
MetLife (MET) director McKenzie credited 169 shares via deferred dividend reinvestment - Stock Titan
[Form 4] METLIFE INC Insider Trading Activity - Stock Titan
MetLife (NYSE: MET) director adds 39 deferred shares via dividends - Stock Titan
MetLife (MET) director Jeh C. Johnson acquires 61 shares through deferred dividend reinvestment - Stock Titan
MetLife (MET) director granted 42 shares via dividend reinvestment - Stock Titan
MetLife (MET) director adds 20 shares via deferred dividend reinvestment - Stock Titan
MetLife (NYSE: MET) director gains 7 shares via deferred compensation plan - Stock Titan
MetLife (NYSE: MET) director gains 678 shares via deferred stock plan - Stock Titan
MetLife (MET) U.S. Business president awarded 127 shares via deferred plan - Stock Titan
AI's Inflationary Impact on Economy, Says MetLife's Drew Matus - GuruFocus
MetLife Broadens Settlement Solutions Portfolio With NQA-FA - Yahoo Finance
MetLife (MET) Unveils Flexible Settlement Agreement for Non-Phys - GuruFocus
MetLife launches deferred payment product for injury settlements - Investing.com
The ’Duck Stock’ Keeps Quietly Making Money for Shareholders - Investing.com
MetLife launches deferred payment product for injury settlements By Investing.com - Investing.com Canada
MetLife Launches New Deferred Payment Option for Non-Physical Injury Claims - marketscreener.com
MetLife Inc at Morgan Stanley US Financials Conference Transcript - GuruFocus
Lincoln National vs. MetLife: Which Financial Stock Is a Better Buy in 2026? - The Globe and Mail
MetLife Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
MetLife Inc. stock (US59156R1086): shares hover near 52-week high after solid Q1 earnings - AD HOC NEWS
$23M Settlement Ends MetLife’s Mortality Table Case - planadviser
Q1 Earnings Roundup: MetLife (NYSE:MET) And The Rest Of The Life Insurance Segment - Yahoo Finance
Metlife stock hits 52-week high at 85.31 USD - Investing.com
Metlife stock hits 52-week high at 85.31 USD By Investing.com - Investing.com Canada
METLIFE INC (NYSE:MET) Shows Strong Breakout Setup with High Technical and Quality Scores - ChartMill
Argus Adjusts Price Target on MetLife to $93 From $90, Maintains Buy Rating - marketscreener.com
MetLife Settles Mortality Table ERISA Lawsuit for $23M - plansponsor
MKL Stock Declines 15.4% in YTD: What Should Investors Do Now? - TradingView
Mortality table settlements for married retirees continue with MetLife’s $23 million agreement - Pensions & Investments
MetLife: Not Exciting, But It Works - Seeking Alpha
These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy? - MarketBeat
Should I Buy MET (MetLife, Inc.) | AI Analysis, Technical & News Insights - Kavout
MetLife (MET) Valuation Check As New Annuity Cancellation Feature Reshapes Income Mix - Yahoo Finance
MetLife Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is MetLife Stock Outperforming the S&P 500? - Yahoo Finance
MetLife Inc (MET) Shares Surge 3.1% -- What GF Score of 77 Tells Investors - GuruFocus
MetLife Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
MetLife earnings in focus as insurers navigate softer market - Investing.com
Goldman Sachs, Johnson & Johnson, MetLife Named Among Newsweek’s World’s Greenest Companies 2026 - Yahoo Finance
MET Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MetLife EVP & CRO Marlene Debel sells $1.74m in shares By Investing.com - Investing.com South Africa
MetLife EVP & CRO Marlene Debel sells $1.74m in shares - Investing.com Australia
MetLife Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
MetLife CFO to Speak at Morgan Stanley US Financials Conference - standard-journal.com
Finanzdaten der Metlife Inc-Aktie (MET)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):